Cargando…
The role of chemotherapy and new targeted agents in the management of primary prostate cancer
While early treatment of primary prostate cancer is very effective, the incidence of primary prostate cancer continues to rise and therefore the detection of men with high-risk non-metastatic prostate cancer and their subsequent management is becoming increasingly important. There continues to be no...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356176/ https://www.ncbi.nlm.nih.gov/pubmed/28344814 http://dx.doi.org/10.1177/2051415816685211 |
_version_ | 1782515766934896640 |
---|---|
author | Kumar, Sanjeev Srinivas Pacey, Simon |
author_facet | Kumar, Sanjeev Srinivas Pacey, Simon |
author_sort | Kumar, Sanjeev Srinivas |
collection | PubMed |
description | While early treatment of primary prostate cancer is very effective, the incidence of primary prostate cancer continues to rise and therefore the detection of men with high-risk non-metastatic prostate cancer and their subsequent management is becoming increasingly important. There continues to be no molecularly-targeted or chemotherapeutic options with proven, statistically significant survival benefit in this setting. However, there are indications that further risk stratification using molecular features could potentially help distinguish indolent from aggressive prostate cancer, ultimately providing biological markers that could guide a more personalised approach to therapy selection. |
format | Online Article Text |
id | pubmed-5356176 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-53561762017-03-23 The role of chemotherapy and new targeted agents in the management of primary prostate cancer Kumar, Sanjeev Srinivas Pacey, Simon J Clin Urol Changing Face of Prostate Cancer Diagnosis and Management While early treatment of primary prostate cancer is very effective, the incidence of primary prostate cancer continues to rise and therefore the detection of men with high-risk non-metastatic prostate cancer and their subsequent management is becoming increasingly important. There continues to be no molecularly-targeted or chemotherapeutic options with proven, statistically significant survival benefit in this setting. However, there are indications that further risk stratification using molecular features could potentially help distinguish indolent from aggressive prostate cancer, ultimately providing biological markers that could guide a more personalised approach to therapy selection. SAGE Publications 2016-12-01 2016-12 /pmc/articles/PMC5356176/ /pubmed/28344814 http://dx.doi.org/10.1177/2051415816685211 Text en © British Association of Urological Surgeons 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Changing Face of Prostate Cancer Diagnosis and Management Kumar, Sanjeev Srinivas Pacey, Simon The role of chemotherapy and new targeted agents in the management of primary prostate cancer |
title | The role of chemotherapy and new targeted agents in the management of primary prostate cancer |
title_full | The role of chemotherapy and new targeted agents in the management of primary prostate cancer |
title_fullStr | The role of chemotherapy and new targeted agents in the management of primary prostate cancer |
title_full_unstemmed | The role of chemotherapy and new targeted agents in the management of primary prostate cancer |
title_short | The role of chemotherapy and new targeted agents in the management of primary prostate cancer |
title_sort | role of chemotherapy and new targeted agents in the management of primary prostate cancer |
topic | Changing Face of Prostate Cancer Diagnosis and Management |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356176/ https://www.ncbi.nlm.nih.gov/pubmed/28344814 http://dx.doi.org/10.1177/2051415816685211 |
work_keys_str_mv | AT kumarsanjeevsrinivas theroleofchemotherapyandnewtargetedagentsinthemanagementofprimaryprostatecancer AT paceysimon theroleofchemotherapyandnewtargetedagentsinthemanagementofprimaryprostatecancer AT kumarsanjeevsrinivas roleofchemotherapyandnewtargetedagentsinthemanagementofprimaryprostatecancer AT paceysimon roleofchemotherapyandnewtargetedagentsinthemanagementofprimaryprostatecancer |